These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 20677779)

  • 1. Product analysis and inhibition studies of a causative Asn to Ser variant of 4-hydroxyphenylpyruvate dioxygenase suggest a simple route to the treatment of Hawkinsinuria.
    Brownlee JM; Heinz B; Bates J; Moran GR
    Biochemistry; 2010 Aug; 49(33):7218-26. PubMed ID: 20677779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of (4-hydroxyphenyl)pyruvate dioxygenase with the specific inhibitor 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione.
    Kavana M; Moran GR
    Biochemistry; 2003 Sep; 42(34):10238-45. PubMed ID: 12939152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-(2-nitro-4-trifluoromethylbenzoyl)-cyclohexane-1,3-dione and 2-(2-chloro-4-methanesulfonylbenzoyl)-cyclohexane-1,3-dione.
    Ellis MK; Whitfield AC; Gowans LA; Auton TR; Provan WM; Lock EA; Smith LL
    Toxicol Appl Pharmacol; 1995 Jul; 133(1):12-9. PubMed ID: 7597701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the ferrous form of (4-hydroxyphenyl)pyruvate dioxygenase from Streptomyces avermitilis in complex with the therapeutic herbicide, NTBC.
    Brownlee JM; Johnson-Winters K; Harrison DH; Moran GR
    Biochemistry; 2004 Jun; 43(21):6370-7. PubMed ID: 15157070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of 4-hydroxyphenylpyruvate dioxygenase by 2-[2-nitro-4-(trifluoromethyl)benzoyl]-1,3-cyclohexanedione.
    Molchanov S; Gryff-Keller A
    Acta Biochim Pol; 2009; 56(3):447-54. PubMed ID: 19621095
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectroscopic and computational studies of NTBC bound to the non-heme iron enzyme (4-hydroxyphenyl)pyruvate dioxygenase: active site contributions to drug inhibition.
    Neidig ML; Decker A; Kavana M; Moran GR; Solomon EI
    Biochem Biophys Res Commun; 2005 Dec; 338(1):206-14. PubMed ID: 16197918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the 4-hydroxyphenylpyruvic acid dioxygenase gene are responsible for tyrosinemia type III and hawkinsinuria.
    Tomoeda K; Awata H; Matsuura T; Matsuda I; Ploechl E; Milovac T; Boneh A; Scott CR; Danks DM; Endo F
    Mol Genet Metab; 2000 Nov; 71(3):506-10. PubMed ID: 11073718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the mechanism of hydroxylation by 4-hydroxyphenylpyruvate dioxygenase and hydroxymandelate synthase from intermediate partitioning in active site variants.
    Shah DD; Conrad JA; Heinz B; Brownlee JM; Moran GR
    Biochemistry; 2011 Sep; 50(35):7694-704. PubMed ID: 21815644
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Hydroxyphenylpyruvate dioxygenase.
    Moran GR
    Arch Biochem Biophys; 2005 Jan; 433(1):117-28. PubMed ID: 15581571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrophobicity-oriented drug design (HODD) of new human 4-hydroxyphenylpyruvate dioxygenase inhibitors.
    Ndikuryayo F; Kang WM; Wu FX; Yang WC; Yang GF
    Eur J Med Chem; 2019 Mar; 166():22-31. PubMed ID: 30684868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Manifestation of hawkinsinuria in a patient compound heterozygous for hawkinsinuria and tyrosinemia III.
    Item CB; Mihalek I; Lichtarge O; Jalan A; Vodopiutz J; Muhl A; Bodamer OA
    Mol Genet Metab; 2007 Aug; 91(4):379-83. PubMed ID: 17560158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of a novel 4-hydroxyphenylpyruvate dioxygenase from the soil metagenome.
    Lee CM; Yeo YS; Lee JH; Kim SJ; Kim JB; Han NS; Koo BS; Yoon SH
    Biochem Biophys Res Commun; 2008 May; 370(2):322-6. PubMed ID: 18381065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue distribution of 2-(2-nitro-4-trifluoromethylbenzoyl)cyclohexane-1-3-dione (NTBC): effect on enzymes involved in tyrosine catabolism and relevance to ocular toxicity in the rat.
    Lock EA; Gaskin P; Ellis MK; Provan WM; Robinson M; Smith LL; Prisbylla MP; Mutter LC
    Toxicol Appl Pharmacol; 1996 Dec; 141(2):439-47. PubMed ID: 8975769
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic, noncatalytic, and inhibitory phenomena: kinetic analysis of (4-hydroxyphenyl)pyruvate dioxygenase from Arabidopsis thaliana.
    Purpero VM; Moran GR
    Biochemistry; 2006 May; 45(19):6044-55. PubMed ID: 16681377
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of a low-protein diet and dietary supplementation of threonine on tyrosine and 2-(2-nitro-4-trifluoromethylbenzoyl) cyclohexane-1,3-dione-induced corneal lesions, the extent of tyrosinemia, and the activity of enzymes involved in tyrosine catabolism in the rat.
    Lock EA; Gaskin P; Ellis MK; Robinson M; Provan WM; Smith LL
    Toxicol Appl Pharmacol; 1998 May; 150(1):125-32. PubMed ID: 9630461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tyrosinemia I, a model for human diseases mediated by 2-oxoacid-utilizing dioxygenases: hepatotoxin suppression by NTBC does not normalize hepatic collagen metabolism.
    Hanauske-Abel HM; Popowicz A; Remotti H; Newfield RS; Levy J
    J Pediatr Gastroenterol Nutr; 2002 Jul; 35(1):73-8. PubMed ID: 12142814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and pharmacodynamics of NTBC (2-(2-nitro-4-fluoromethylbenzoyl)-1,3-cyclohexanedione) and mesotrione, inhibitors of 4-hydroxyphenyl pyruvate dioxygenase (HPPD) following a single dose to healthy male volunteers.
    Hall MG; Wilks MF; Provan WM; Eksborg S; Lumholtz B
    Br J Clin Pharmacol; 2001 Aug; 52(2):169-77. PubMed ID: 11488774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and bioevaluation of pyrazole-benzimidazolone hybrids as novel human 4-Hydroxyphenylpyruvate dioxygenase inhibitors.
    Xu YL; Lin HY; Ruan X; Yang SG; Hao GF; Yang WC; Yang GF
    Eur J Med Chem; 2015 Mar; 92():427-38. PubMed ID: 25590863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of para-Hydroxyphenylpyruvate Dioxygenase by Analogues of the Herbicide Nitisinone As a Strategy to Decrease Homogentisic Acid Levels, the Causative Agent of Alkaptonuria.
    Laschi M; Bernardini G; Dreassi E; Millucci L; Geminiani M; Braconi D; Marzocchi B; Botta M; Manetti F; Santucci A
    ChemMedChem; 2016 Apr; 11(7):674-8. PubMed ID: 26947423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolation of herbicide-resistant 4-hydroxyphenylpyruvate dioxygenase from cultured Coptis japonica cells.
    Liang Y; Minami H; Sato F
    Biosci Biotechnol Biochem; 2008 Nov; 72(11):3059-62. PubMed ID: 18997404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.